X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

期刊標題檢索 DRUG DEV IND PH 最新評論: A while ago, I complained that my article was not accepted. These day... (2023-02-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY]您好,您是該頁面的第 52754 位訪客。

期刊簡介
期刊名稱DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LetPub Score
5.5
50 ratings
Rate

Reputation
6.4

Influence
4.2

Speed
8.1

期刊簡稱DRUG DEV IND PHARM
ISSN0363-9045
E-ISSN1520-5762
h-index78
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.800.4750.684
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q144 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Organic Chemistry
Q254 / 211
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q296 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q249 / 157

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
The aim of Drug Development and Industrial Pharmacy is to publish novel, original, peer-reviewed research manuscripts within relevant topics and research methods related to pharmaceutical research and development, and industrial pharmacy. Research papers must be hypothesis driven and emphasize innovative breakthrough topics in pharmaceutics and drug delivery. The journal will also consider timely critical review papers.
官方網站http://informahealthcare.com/journal/ddi
在線稿件提交http://mc.manuscriptcentral.com/lddi
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年0
每年文章數83每年文章數趨勢
黃金OA百分比3.22%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MEDICINALSCIEQ350/72
PHARMACOLOGY & PHARMACYSCIEQ3188/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0363-9045%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498326
    PHYTOMEDICINE340266
    LIFE SCIENCES285753
    International Journal of Pharmaceutics242438
    PHARMACOLOGICAL RESEARCH241277
    European Journal of Pharmacology204238
    BIOCHEMICAL PHARMACOLOGY202690
    JOURNAL OF NATURAL PRODUCTS196695
    BRITISH JOURNAL OF PHARMACOLOGY165139
    MOLECULAR PHARMACEUTICS162832
  •  

    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY] 的評論撰寫評論
作者: Lynn-Z-L


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-01 09:19:47 評論於
A while ago, I complained that my article was not accepted. These days, I found that the article has been accepted. Submitted on 06-Sep-2022; Decisioned on 31-Jan-2023. It was revised once in between. Overall, it looks good.
(0) 讚! | Lynn-Z-L

作者: Lynn-Z-L


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-24 19:54:06 評論於
Too slow~ Not recommended for submission! Submitted on August 1, 2022, and revised in September. It's now the end of January 2023, and there's still no news. Sent a reminder but no response.
(0) 讚! | Lynn-Z-L

作者: Smokey


領域: 医学
審稿時間: 7.0 month(s)
結果: 修改後接受


撰寫評論

2022-07-16 18:23:01 評論於
A very conscientious magazine, very good.
(0) 讚! | Smokey

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:26:12 評論於
A letter is a type of research article published in journals, usually shorter in length and with limited research data
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:43:11 評論於
A research article is the main type of research paper published in journals, which generally has a longer length and a larger amount of research data
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 13:48:29 評論於
What does research article mean?
(0) 讚! | 八坂篷蔚

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 09:57:24 評論於
What is a letter?
(0) 讚! | 破戒阳平

作者: Smokey


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2021-07-29 15:35:24 評論於
First trial took five months, after modification, the review took two months, and the employment notice was issued in July.
(0) 讚! | Smokey

作者: www 嗯嗯


領域: 医药科学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2018-03-15 10:11:56 評論於
very slow, not generally slow, is particularly slow
(0) 讚! | www 嗯嗯

作者: 魔都芸欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-03-15 08:46:47 評論於
Extremely slow, not just slow, but exceptionally slow
(0) 讚! | 魔都芸欣

作者: 明冠岚翠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-16 19:53:57 評論於
Review Speed: 6.0
Experience Sharing: The review process is extremely slow, with only one reviewer providing feedback. The initial review takes 6 months, the second review takes one and a half months, and the third review takes one month. It is exceptionally slow
(0) 讚! | 明冠岚翠

作者: 512014866@qq.com


領域: 医药科学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2017-11-16 13:28:30 評論於
review was particularly slow, and finally the opinions of a reviewer were 6 months for the first trial, one and a half months for the second trial, and one month for the third trial.Not generally slow.
(0) 讚! | 512014866@qq.com

作者: Alvin Toland


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-14 10:55:04 評論於
Is this magazine free?
(0) 讚! | Alvin Toland

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 20:11:57 評論於
Too ruthless! With such a big drop, who dares to invest in the future?
(0) 讚! | 凌霄高洁

作者: 灵慧酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-10-28 09:39:25 評論於
Is there a fee?
(0) 讚! | 灵慧酱大魔王

作者: 极乐玉淇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-11-20 18:53:57 評論於
Is there more submission experience you can share? Thank you
(0) 讚! | 极乐玉淇

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-01-02 19:14:03 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: Carefully edit the language and try to cite as many articles from the journal in recent years as possible
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-11-28 17:23:54 評論於
This magazine is relatively easy to get published in. It is recommended to include as many citations from the magazine as possible before submitting a manuscript. The editor-in-chief values this very much
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-30 17:35:37 評論於
Surprise, last year it was just over 1 point, this year it has jumped to over 2 points, but once it surpasses 3 points, it is equivalent to passing the threshold, and it will be easy from then on
(0) 讚! | 凌霄高洁

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2012-02-11 13:29:00 評論於
This journal is biased towards industry reviews. There are hardly any review articles on theory; most are on the practical application drugs. The review period is fast, however – about 2.5 months.

(0) 讚! | 匿名

作者: 东京千霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-02-11 13:03:29 評論於
Focused on industrial pharmaceuticals, not particularly theoretical, but emphasizes practicality. The review process is now faster, and I received the first review comments in 2 and a half months
(0) 讚! | 东京千霜

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-02-05 11:17:39 評論於
Review speed: 6.0 | Submission success rate: 75.0
Experience sharing: One of my articles was accepted, feeling a bit lucky
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-09-04 18:48:59 評論於
Can experts who know please introduce their experience in contributing to this magazine? Thank you!
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*